Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice

British Journal of Nutrition

Volumn 112, Issue 1, 2014, Pages 1-7

  Ritze, Yvonne ^a   Bárdos, Gyöngyi ^a   Hubert, Astrid ^a   Böhle, Maureen ^a   Bischoff, Stephan C ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Intestinal permeability; Non alcoholic fatty liver disease; Serotonin; Serotonin re uptake transporter; Tryptophan

Indexed keywords

LIPOPOLYSACCHARIDE; OCCLUDIN; SEROTONIN; SEROTONIN TRANSPORTER; TRIACYLGLYCEROL; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DUODENUM; HISTOLOGY; INTESTINE MOTILITY; INTESTINE MUCOSA PERMEABILITY; LIPID STORAGE; LIVER WEIGHT; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SUPPLEMENTATION; TIGHT JUNCTION; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ANIMAL FOOD; CARBOHYDRATE DIET; DIET SUPPLEMENTATION; DISEASE COURSE; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GLUCOSE BLOOD LEVEL; HEPATOBILIARY PARAMETERS; LIVER WEIGHT BODY WEIGHT RATIO; SEROTONIN METABOLISM;

MUS;

ANIMALS; BIOLOGICAL TRANSPORT; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DUODENUM; ENZYME INDUCTION; FATTY LIVER; GASTROINTESTINAL MOTILITY; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED C57BL; OCCLUDIN; ORGAN SIZE; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; TIGHT JUNCTIONS; TRIGLYCERIDES; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE;

EID: 84902549987     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514000440     Document Type: Article

References (33)

1. Byrne CD (2012) Dorothy Hodgkin lecture 2012: nonalcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. Diabet Med 29, 1098-1107.
2. Adams KF, Schatzkin A, Harris TB, et al. (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355, 763-778.
3. Adams LA, Lymp JF, St Sauver J, et al. (2005) The natural history of nonalcoholic fatty liver disease: a populationbased cohort study. Gastroenterology 129, 113-121.
4. Spruss A & Bergheim I (2009) Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. J Nutr Biochem 20, 657-662.
5. Bergheim I, Weber S, Vos M, et al. (2008) Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48, 983-992.
6. de Wit NJ, Afman LA, Mensink M, et al. (2012) Phenotyping the effect of diet on non-alcoholic fatty liver disease. J Hepatol 57, 1370-1373.
7. Haub S, Kanuri G, Volynets V, et al. (2010) Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice. Am J Physiol Gastrointest Liver Physiol 298, G335-G344.
8. Malhi H & Gores GJ (2008) Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 28, 360-369.
9. Tetri LH, Basaranoglu M, Brunt EM, et al. (2008) Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 295, G987-G995.
10. Thuy S, Ladurner R, Volynets V, et al. (2008) Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 138, 1452-1455.
11. Haub S, Ritze Y, Ladel I, et al. (2011) Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice. J Pharmacol Exp Ther 339, 790-798.
12. Weber S, Volynets V, Kanuri G, et al. (2009) Treatment with the 5-HT3 antagonist tropisetron modulates glucose-induced obesity in mice. Int J Obes (Lond) 33, 1339-1347.
13. Wade PR, Chen J, Jaffe B, et al. (1996) Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 16, 2352-2364.
14. Gershon MD (2004) Review Article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 20, Suppl. 7, 3-14.
15. Haub S, Ritze Y, Bergheim I, et al. (2010) Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter. Neurogastroenterol Motil 22, 826-834, e229.
16. Bischoff SC, Mailer R, Pabst O, et al. (2009) Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am J Physiol Gastrointest Liver Physiol 296, G685-G695.
17. Nylander O & Pihl L (2006) Luminal hypotonicity increases duodenal mucosal permeability by a mechanism involving 5-hydroxytryptamine. Acta Physiol (Oxf) 186, 45-58.
18. Stull MA, Pai V, Vomachka AJ, et al. (2007) Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions. Proc Natl Acad Sci U S A 104, 16708-16713.
19. Yamada T, Inui A, Hayashi N, et al. (2003) Serotonin stimulates endotoxin translocation via 5-HT3 receptors in the rat ileum. Am J Physiol Gastrointest Liver Physiol 284, G782-G788. (Pubitemid 36437978)
20. Noguchi T, Nishino M & Kido R (1973) Tryptophan 5-hydroxylase in rat intestine. Biochem J 131, 375-380.
21. Ozer C, Gonul B, Ercan ZS, et al. (2007) The effect of tryptophan administration on ileum contractility and oxidant status in mice. Amino Acids 32, 453-458.
22. Ozer C, Gonul B, Take G, et al. (2004) Tryptophan administration increase contractility and change the ultrastructure of mice duodenum. Amino Acids 27, 215-220.
23. Akiba Y, Takahashi K, Horiguchi M, et al. (1992) L-Tryptophan alleviates fatty liver and modifies hepatic microsomal mixed function oxidase in laying hens. Comp Biochem Physiol Comp Physiol 102, 769-774.
24. Rogers SR & Pesti GM (1992) Effects of tryptophan supplementation to a maize-based diet on lipid metabolism in laying hens. Br Poult Sci 33, 195-200.
25. Lesurtel M, Soll C, Graf R, et al. (2008) Role of serotonin in the hepato-gastrointestinal tract: an old molecule for new perspectives. Cell Mol Life Sci 65, 940-952.
26. Kleiner DE, Brunt EM, Van Natta M, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321.
27. Brun P, Castagliuolo I, Di Leo V, et al. (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292, G518-G525.
28. Cani PD, Bibiloni R, Knauf C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481.
29. Fears R & Murrell EA (1980) Tryptophan and the control of triglyceride and carbohydrate metabolism in the rat. Br J Nutr 43, 349-356.
30. Teichberg S, Wapnir RA, Zdanowicz M, et al. (1989) Morphologic and functional alterations in absorptive epithelial cells during L-tryptophan induced inhibition of net sodium and fluid absorption in the rat ileum. Lab Invest 60, 88-101.
31. Sakurai T, Miyazawa S, Shindo Y, et al. (1974) The effect of tryptophan administration on fatty acid synthesis in the liver of the fasted normal rat. Biochim Biophys Acta 360, 275-288.
32. Nagano J, Shimizu M, Hara T, et al. (2013) Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation. PLoS One 8, e73404.
33. Turner JR (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9, 799-809.